Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study

[1]  L. Leocani,et al.  Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis , 2021, Frontiers in Neuroscience.

[2]  C. Soto,et al.  Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer’s Disease , 2021, Cells.

[3]  L. Cai,et al.  Diversity of Adult Neural Stem and Progenitor Cells in Physiology and Disease , 2021, Cells.

[4]  Qilong Cao,et al.  Neural stem cell secretome and its role in the treatment of neurodegenerative disorders. , 2020, Journal of integrative neuroscience.

[5]  L. Atzori,et al.  Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing–Remitting and Primary Progressive Multiple Sclerosis , 2020, Journal of clinical medicine.

[6]  S. Ourselin,et al.  Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial , 2020, The Lancet Neurology.

[7]  R. Gold,et al.  Progressive multiple sclerosis: from pathophysiology to therapeutic strategies , 2019, Nature Reviews Drug Discovery.

[8]  Martin H. Pham,et al.  Immunosuppressive mechanisms for stem cell transplant survival in spinal cord injury. , 2019, Neurosurgical focus.

[9]  Zhibo Wang,et al.  Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs , 2018, Contemporary clinical trials communications.

[10]  Jeffrey A. Cohen,et al.  Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis , 2018, Multiple sclerosis.

[11]  Stephen M. Rao,et al.  Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward , 2017, Journal of the International Neuropsychological Society.

[12]  G. Comi,et al.  Neural precursor cell–secreted TGF-&bgr;2 redirects inflammatory monocyte-derived cells in CNS autoimmunity , 2017, The Journal of clinical investigation.

[13]  M. Battaglini,et al.  Brain MRI atrophy quantification in MS , 2017, Neurology.

[14]  Xavier Lladó,et al.  Automated tissue segmentation of MR brain images in the presence of white matter lesions , 2017, Medical Image Anal..

[15]  R. Benedict,et al.  Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine , 2016, Expert review of neurotherapeutics.

[16]  J. A. Kim,et al.  Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer's disease mouse model , 2015, Cell Death and Disease.

[17]  K. Alitalo,et al.  Vascular Endothelial Growth Factor Receptor 3 Controls Neural Stem Cell Activation in Mice and Humans , 2015, Cell reports.

[18]  E. Ruppin,et al.  Fumarate induces redox-dependent senescence by modifying glutathione metabolism , 2015, Nature Communications.

[19]  Turi O. Dalaker,et al.  Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  Thomas Kohlmann,et al.  Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis , 2013, BMC Neurology.

[21]  M. Horsfield,et al.  Gray matter damage predicts the accumulation of disability 13 years later in MS , 2013, Neurology.

[22]  G. Comi,et al.  iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF , 2013, Nature Communications.

[23]  Gerard R. Ridgway,et al.  Symmetric Diffeomorphic Modeling of Longitudinal Structural MRI , 2013, Front. Neurosci..

[24]  M. Battaglini,et al.  Evaluating and reducing the impact of white matter lesions on brain volume measurements , 2012, Human brain mapping.

[25]  O. Lindvall,et al.  Cross-talk between neural stem cells and immune cells: the key to better brain repair? , 2012, Nature Neuroscience.

[26]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[27]  D. Gomez-Nicola,et al.  Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells , 2011, Molecular biology of the cell.

[28]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[29]  B. Choi,et al.  Granulocyte macrophage-colony stimulating factor shows anti-apoptotic activity in neural progenitor cells via JAK/STAT5-Bcl-2 pathway , 2011, Apoptosis.

[30]  David H. Miller,et al.  Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial , 2010, The Lancet Neurology.

[31]  R. Franklin,et al.  Stem cell transplantation in multiple sclerosis: current status and future prospects , 2010, Nature Reviews Neurology.

[32]  M. A. Horsfield,et al.  Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosis , 2010, NeuroImage.

[33]  S. Nicolis,et al.  Sox2 roles in neural stem cells. , 2010, The international journal of biochemistry & cell biology.

[34]  Y. Mao-Draayer,et al.  Fas activation increases neural progenitor cell survival , 2009, Journal of neuroscience research.

[35]  G. Comi,et al.  Human neural stem cells ameliorate autoimmune encephalomyelitis in non‐human primates , 2009, Annals of neurology.

[36]  J. L. Cox,et al.  Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[37]  M Rovaris,et al.  Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  E. Snyder,et al.  Gene therapy: can neural stem cells deliver? , 2006, Nature Reviews Neuroscience.

[39]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Mitchel S Berger,et al.  Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.

[41]  G. Comi,et al.  Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism , 2005, Nature.

[42]  K. Boheler,et al.  Nestin expression – a property of multi-lineage progenitor cells? , 2004, Cellular and Molecular Life Sciences CMLS.

[43]  David J Torgerson,et al.  Effect of regression to the mean on decision making in health care , 2003, BMJ : British Medical Journal.

[44]  Angelo L. Vescovi,et al.  Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis , 2003, Nature.

[45]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[46]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[47]  Mart Saarma,et al.  The GDNF family: Signalling, biological functions and therapeutic value , 2002, Nature Reviews Neuroscience.